The Edinburgh spinout has been backed by Mercia Fund Managers to support development of its kidney dialysis camouflage coating.

Invizius, a UK-based dialysis camouflage coating developer spun out from University of Edinburgh, has obtained £500,000 ($680,000) in capital from Mercia Fund Managers, a VC subsidiary of Mercia Technologies, Scottish Business News Network has reported.

The deal represents Mercia’s first investment under a partnership with University of Edinburgh launched in November 2017.

Invizius is developing an anti-inflammatory and anti-coagulant product called H-Guard that can be used to coat kidney dialysis filters before they are inserted into a patient’s blood.

The coating is designed to…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?